News
🇺🇸 FDA Page 6Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 61–72 of 807 articles
Danuglipron Phase 3 Watch After Pfizer’s Phase 2b Obesity Win
obesity · 6 min
Dr. Sarah MitchellBiogen and Eisai expand Leqembi access with subcutaneous maintenance dosing
Alzheimer's disease · 5 min
Dr. Sarah MitchellFDA approves Vyloy for HER2-negative gastric and GEJ cancer
FDA · HER2-negative gastric cancer · 5 min
Dr. Sarah MitchellNovo Nordisk supply of Wegovy stabilizes as FDA shortage ends
FDA · weight-loss · 5 min
Dr. Sarah MitchellJ&J reports positive Phase 3 Tremfya data in ulcerative colitis
CHMP · ulcerative colitis · 7 min
Dr. Sarah MitchellSanofi completes Inhibrx acquisition for $1.7B
inflammation · 4 min
Dr. Sarah MitchellMariTide Phase 2: Amgen reports up to 20% weight loss at one year
obesity · 5 min
Dr. Sarah MitchellFDA approves Dupixent for COPD with eosinophilic phenotype
FDA · chronic obstructive pulmonary disease · 6 min
Dr. Sarah MitchellGSK Blenrep wins FDA approval in relapsed multiple myeloma
FDA · blood cancer · 6 min
Dr. Sarah MitchellMerck’s Harpoon acquisition deepens oncology pipeline ahead of Keytruda risk
oncology · 5 min
Dr. Sarah MitchellPfizer's Danuglipron Hits Phase 2b Obesity Endpoint
obesity · 7 min
Dr. Sarah MitchellRoche reports positive Phase 3 results for trontinemab in Alzheimer's disease
EMA · Alzheimer's disease · 5 min
Dr. Sarah MitchellPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways